BMC Medical Co

BMC Medical Co EBITDA per Share

The EBITDA per Share of BMC Medical Co (301367.SZ) as of Nov 2, 2026 is 2.70 CNY. In the previous year, EBITDA per Share was 1.51 CNY — a change of 78.75% (higher).

EBITDA per Share

2.70CNY

YoY

78.75%

Last updated:

EBITDA per Share of BMC Medical Co is 2025 2.70 CNY. EBITDA per Share of BMC Medical Co was 2024 1.51 CNY. It decreases by 78.75% higher compared to the previous year.

The BMC Medical Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
0.70 CNY
Jan 1, 2020
6.29 CNY
Jan 1, 2021
1.81 CNY
Jan 1, 2022
4.64 CNY
Jan 1, 2023
3.36 CNY
Jan 1, 2024
1.51 CNY
Jan 1, 2025
2.70 CNY
The BMC Medical Co EBITDA per Share history
YEAREBITDA per ShareYoY
2.70CNY+78.75%
1.51CNY-55.04%
3.36CNY-27.66%
4.64CNY+156.41%
1.81CNY-71.22%
6.29CNY+803.27%
0.70CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BMC Medical Co Stock analysis

What does BMC Medical Co do? BMC Medical Co. Ltd. generates revenue through the research, development, production, and sale of medical equipment and consumable products focused on respiratory health. The company offers non-invasive home ventilators, ventilation masks, sleep monitors, and high-flow humidified oxygen therapy devices. Its primary customers are patients with sleep apnea-hypopnea syndrome (SAHS), particularly obstructive sleep apnea syndrome (OSA), and patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD). The firm provides chronic disease management services as part of its full-cycle treatment solutions. The company's product portfolio includes non-invasive home ventilators, ventilation masks, sleep monitors, and high-flow humidified oxygen therapy devices, all designed for respiratory health applications. These products target patients suffering from OSA and COPD, addressing both acute and chronic respiratory conditions. BMC Medical Co. Ltd. focuses on delivering comprehensive treatment services through a multi-scenario approach for these specific patient segments. Revenue streams are derived from the sale of medical equipment and consumables, as well as chronic disease management services. The company's services are tailored for patients with SAHS and COPD, providing integrated solutions across the treatment cycle. This includes both the physical products and the ongoing management support for long-term respiratory health needs. BMC Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BMC Medical Co stock

EBITDA per Share of BMC Medical Co is 2.70 CNY in 2025.

EBITDA per Share of BMC Medical Co changed from 1.51 CNY to 2.70 CNY, representing a 78.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share BMC Medical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — BMC Medical Co

All Key Metrics — BMC Medical Co